UT Health San Antonio, in partnership with University Health System, wrapped up phase two of the international clinical trial of the experimental antiviral drug, remdesivir, at the end of June.

While the results have not been finalized, Thomas Patterson, Infectious  Disease, said that extremely sick patients “felt significantly better almost immediately” following remdesivir.

Read the story.

The post Rivard Report: San Antonio scientists running largest remdesivir trial in world find early success appeared first on UT Health San Antonio.